ACAD
19.36
-0.93
-4.58%
AEMD
4.9
-1.1
-18.33%
APRI
1.17
-0.03
-2.50%
ARNA
1.57
-0.04
-2.48%
ATEC
0.4
+0.01
+1.32%
CNAT
1.84
-0.01
-0.54%
CRXM
0.25
0.00
0.00%
CYTX
0.179
-0.011
-5.6345%
DXCM
61.98
-8.65
-12.25%
GNMK
5.08
-0.42
-7.64%
HALO
7.9
-0.37
-4.47%
ILMN
136.05
-7.33
-5.11%
INNV
0.038
-0.002
-5.2500%
INO
6.01
-0.25
-3.99%
ISCO
2.4
+0.13
+5.73%
ISIS
57.56
0.00
0.00%
LGND
92.5
-6.44
-6.51%
LPTN
0.16
-0.015
-8.5143%
MBVX
0.54
-0.02
-3.55%
MEIP
1.24
0.00
0.00%
MNOV
4.15
-0.14
-3.26%
MRTX
20.26
-1.1
-5.15%
MSTX
0.41
+0.01
+2.4506%
NBIX
35.99
-1.08
-2.91%
NUVA
41.45
-2.98
-6.71%
ONCS
1.69
-0.01
-0.59%
ONVO
2.09
-0.21
-9.13%
OREX
1.84
-0.05
-2.65%
OTIC
13.8
-0.25
-1.78%
QDEL
16.4
-0.49
-2.90%
RCPT
231.96
0.00
0.00%
RGLS
5.94
-0.41
-6.46%
RMD
57.42
-0.4
-0.69%
SCIE
0.001
0.00
+11.111%
SPHS
1.68
-0.09
-5.08%
SRNE
5.05
+0.04
+0.80%
TROV
3.85
-0.13
-3.27%
VICL
0.333
-0.007
-1.9741%
VOLC
18
0.00
0.00%
ZGNX
8.49
-0.41
-4.61%
ACAD
19.36
-0.93
-4.58%
AEMD
4.9
-1.1
-18.33%
APRI
1.17
-0.03
-2.50%
ARNA
1.57
-0.04
-2.48%
ATEC
0.4
+0.01
+1.32%
CNAT
1.84
-0.01
-0.54%
CRXM
0.25
0.00
0.00%
CYTX
0.179
-0.011
-5.6345%
DXCM
61.98
-8.65
-12.25%
GNMK
5.08
-0.42
-7.64%
HALO
7.9
-0.37
-4.47%
ILMN
136.05
-7.33
-5.11%
INNV
0.038
-0.002
-5.2500%
INO
6.01
-0.25
-3.99%
ISCO
2.4
+0.13
+5.73%
ISIS
57.56
0.00
0.00%
LGND
92.5
-6.44
-6.51%
LPTN
0.16
-0.015
-8.5143%
MBVX
0.54
-0.02
-3.55%
MEIP
1.24
0.00
0.00%
MNOV
4.15
-0.14
-3.26%
MRTX
20.26
-1.1
-5.15%
MSTX
0.41
+0.01
+2.4506%
NBIX
35.99
-1.08
-2.91%
NUVA
41.45
-2.98
-6.71%
ONCS
1.69
-0.01
-0.59%
ONVO
2.09
-0.21
-9.13%
OREX
1.84
-0.05
-2.65%
OTIC
13.8
-0.25
-1.78%
QDEL
16.4
-0.49
-2.90%
RCPT
231.96
0.00
0.00%
RGLS
5.94
-0.41
-6.46%
RMD
57.42
-0.4
-0.69%
SCIE
0.001
0.00
+11.111%
SPHS
1.68
-0.09
-5.08%
SRNE
5.05
+0.04
+0.80%
TROV
3.85
-0.13
-3.27%
VICL
0.333
-0.007
-1.9741%
VOLC
18
0.00
0.00%
ZGNX
8.49
-0.41
-4.61%
Home » Archive by Category

Xconomy

My Déjà Vu Moment in Genomics: Why We Need Industry Standards Now

September 29, 2015 – 2:40 am

I am a serial entrepreneur who has spent the past couple of decades advancing the front lines of technology in digital healthcare, wireless communications, and semiconductor industries. And I’ve been…

[[Click headline to continue reading.]]

Dunsire, Forum Search For Answers After FDA Halts Alzheimer’s Trial

September 29, 2015 – 12:00 am

A litany of promising therapies for Alzheimer’s disease have crashed and burned in late-stage testing. So it was an ominous sign when the FDA recently placed a clinical hold on a big Phase 3 trial…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and More

September 25, 2015 – 7:54 am

Those of you who thought that DreamWorks’ Shrek franchise ended in 2010 with Shrek Ever After may have been surprised when a new installment played out over the past week with the big green ogre…

[[Click headline to continue reading.]]

Shkreli Implodes And Provides Hillary A Perfect Medicare Moment

September 23, 2015 – 3:46 pm

It was already a good political time for Hillary Clinton to unveil her plan to control the cost of prescription drugs. Martin Shkreli made it perfect. As you’ve probably heard by now, the…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Google/Insel, SeaGen, Avalon, Alector & More

September 18, 2015 – 4:31 am

It’s not specific to the West Coast, but anyone who needs to catch up on the week’s events should read the British Medical Journal’s re-analysis of a long-criticized study, dubbed…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Google/Insel, SeaGen, Avalon, Alector & More

September 18, 2015 – 4:31 am

It’s not specific to the West Coast, but anyone who needs to catch up on the week’s events should read the British Medical Journal’s re-analysis of a long-criticized study, dubbed…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Google/Insel, SeaGen, Avalon, Alector & More

September 18, 2015 – 4:31 am

It’s not specific to the West Coast, but anyone who needs to catch up on the week’s events should read the British Medical Journal’s re-analysis of a long-criticized study, dubbed…

[[Click headline to continue reading.]]

Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy

September 18, 2015 – 3:00 am

There’s a lot of excitement these days about a type of cellular immunotherapy known as CAR-T, a method of modifying peoples’ immune cells to fight cancer. But you could also fill a book listing all…

[[Click headline to continue reading.]]

Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy

September 18, 2015 – 3:00 am

There’s a lot of excitement these days about a type of cellular immunotherapy known as CAR-T, a method of modifying peoples’ immune cells to fight cancer. But you could also fill a book listing all…

[[Click headline to continue reading.]]

Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy

September 18, 2015 – 3:00 am

There’s a lot of excitement these days about a type of cellular immunotherapy known as CAR-T, a method of modifying peoples’ immune cells to fight cancer. But you could also fill a book listing all…

[[Click headline to continue reading.]]